BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 3, 2024
See today's BioWorld MedTech
Home
» Carl Zeiss Meditec receives FDA approval for latest femtosecond laser
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Carl Zeiss Meditec receives FDA approval for latest femtosecond laser
Jan. 24, 2024
By
Shani Alexander
No Comments
Carl Zeiss Meditec AG recently received U.S. FDA clearance for the latest generation of its femtosecond laser, the Visumax 800, with its Smile pro software, for surgically treating nearsightedness, with or without astigmatism.
BioWorld MedTech
Regulatory
Ophthalmic
U.S.
FDA